Lessons learnt from post-infectious IBS

Frontiers in Physiology

Volumn 2 AUG, Issue , 2011, Pages

  Sarna, Sushil K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Enteric neurons; Epithelial permeability; Functional bowel disorders; Gut inflammation; Immune cells; Inflammatory bowel disease; Smooth muscle; Visceral pain

Indexed keywords

EID: 84862327578     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00049     Document Type: Article

References (110)

1. Al-Chaer, E. D., Kawasaki, M., and Pasricha, P. J. (2000). A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119, 1276-1285.
2. Bampton, P. A., Dinning, P. G., Kennedy, M. L., Lubowski, D. Z., De Carle, D., and Cook, I. J. (2000). Spatial and temporal organization of pressure patterns throughout the unprepared colon during spontaneous defecation. Am. J. Gastroenterol. 95, 1027-1035.
3. Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., Collins, S. M., and Corinaldesi, R. (2004). Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126, 693-702.
4. Barbara, G., Wang, B., Stanghellini, V., De Giorgio, R., Cremon, C., Di Nardo, G., Trevisani, M., Campi, B., Geppetti, P., Tonini, M., Bunnett, N. W., Grundy, D., and Corinaldesi, R. (2007). Mast cell dependent excitation of visceral nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132, 26-37.
5. Barreau, F., Cartier, C., Ferrier, L., Fioramonti, J., and Bueno, L. (2004). Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats. Gastroenterology 127, 524-534.
6. Bassotti, G., Chistolini, F., Marinozzi, G., and Morelli, A. (2003). Abnormal colonic propagated activity in patients with slow transit constipation and constipation predominant irritable bowel syndrome. Digestion 68, 178-183.
7. Bassotti, G., Gaburri, M., Imbimbo, B. P., Rossi, L., Farroni, F., Pelli, M. A., and Morelli, A. (1988). Colonic mass movements in idiopathic chronic constipation. Gut 29, 1173-1179.
8. Bassotti, G., Iantorno, G., Fiorella, S., Bustos Fernandez, L., and Bilder, C. R. (1999). Colonic motility in man: featuresinnormal subjects and in patients with chronic idiopathic constipation. Am. J. Gastroenterol. 94, 1760-1770.
9. Bhaumik, S. R., Smith, E., and Shilatifard, A. (2007). Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 14, 1008-1016.
10. Brandt, L. J., Bjorkman, D., Fennerty, M. B., Locke, G. R., Olden, K., Peterson, W., Quigley, E., Schoenfeld, P., Schuster, M., and Talley, N. (2002). Systematic review on the management of irritable bowel syndrome in North America. Am. J. Gastroenterol. 97(11 Suppl.), S7-S26.
11. Brierley, S. M., Jones, R. C. III, Gebhart, G. F., and Blackshaw, L. A. (2004). Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice. Gastroenterology 127, 166-178.
12. Bulbring, E., and Crema, A. (1959). The release of 5 hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J. Physiol. (Lond) 146, 18-28.
13. Butler, L. M., Zhou, X., Xu, W. S., Scher, H. I., Rifkind, R. A., Marks, P. A., and Richon, V. M. (2002). The histone deacetylase inhibitor SAHA arrests cancer cell growth, up regulates thioredoxin binding protein 2, and down regulates thioredoxin. Proc. Natl. Acad. Sci. U.S.A. 99, 11700-11705.
14. Camilleri, M., Andrews, C. N., Bharucha, A. E., Carlson, P. J., Ferber, I., Stephens, D., Smyrk, T. C., Urrutia, R., Aerssens, J., Thielemans, L., Göhlmann, H., Van den Wyngaert, I., and Coulie, B. (2007). Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 132, 17-25.
15. Camilleri, M., Atanasova, E., Carlson, P. J., Ahmad, U., Kim, H. J., Viramontes, B. E., McKinzie, S., and Urrutia, R. (2002). Serotonin transporter polymorphism pharma cogenetics in diarrhea predominant irritable bowel syndrome. Gastroenterology 123, 425-432.
16. Camilleri, M., McKinzie, S., Busciglio, I., Low, P. A., Sweetser, S., Burton, D., Baxter, K., Ryks, M., and Zinsmeister, A. R. (2008). Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 6, 772-781.
17. Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., Sharkey, K. A., Ferraz, J. G., Shaffer, E., and Vergnolle, N. (2007). Role for protease activity in visceral pain in irritable bowel syndrome. J. Clin. Invest. 117, 636-647.
18. Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., and Wilson, I. (2002). Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122, 1778-1783.
19. Chang, L., Munakata, J., Mayer, E. A., Schmulson, M. J., Johnson, T. D., Bernstein, C. N., Saba, L., Naliboff, B., Anton, P. A., and Matin, K. (2000). Perceptual responses in patients with inflammatory and functional bowel disease. Gut 47, 497-505.
20. Chaudhary, N. A., and Truelove, S. C. (1962). The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q. J. Med. 31, 307-322.
21. Chavez, A. M., Menconi, M. J., Hodin, R. A., and Fink,M. P. (1999). Cytokine induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit. Care Med. 27, 2246-2251.
22. Chey, W. Y., Jin, H. O., Lee, M. H., Sun, S. W., and Lee, K. Y. (2001). Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am. J. Gastroenterol. 96, 1499-1506.
23. Childs, B. (1995). "A logic of disease," in The Metabolic and Molecular Bases of Inherited Disease, 7th Edn, eds C. R. Scriver, W. S. Sly, B. Childs, A. L. Beaudet, D. Valle, K. W. Kinzler, and B. Vogelstein (New York, NY: Mcgraw Hill), 229-257.
24. Chitkara, D. K., Van Tilburg, M. A., Blois Martin, N., and Whitehead, W. E. (2008). Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am. J. Gastroenterol. 103, 765-774; quiz 775.
25. Choi, K., Chen, J., Mitra, S., and Sarna, S. K. (2011a). Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology. PMID: 21745450. [Epub ahead of print].
26. Choi, K., Shi, X. Z. P., and Sarna, S. K. (2011b). Epigenetic modulation of Mlck1 gene contributes to delayed gastric emptying in a rat model of functional dyspepsia. Gastroenterology 140, S70-S71.
27. Choudhury, B. K., Shi, X. Z., and Sarna, S. K. (2009). Gene plasticity in colonic circular smooth muscle cells underlies motility dysfunction in a model of postinfective IBS. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G632-G642.
28. Christensen, D. P., Dahllöf, M., Lundh, M., Rasmussen, D. N., Nielsen, M. D., Billestrup, N.,Grunnet, L. G., and Mandrup Poulsen, T. (2011). Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol. Med. 17, 378-390.
29. Coates, M. D., Mahoney, C. R., Linden, D. R., Sampson, J. E., Chen, J., Blaszyk, H., Crowell, M. D., Sharkey, K. A., Gershon, M. D., Mawe, G. M., and Moses, P. L. (2004). Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126, 1657-1664.
30. Corinaldesi, R., Stanghellini, V., Cremon, C., Gargano, L., Cogliandro, R. F., De Giorgio, R., Bartesaghi, G., Canovi, B., and Barbara, G. (2009). Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome:arandomized controlled proof of concept study. Aliment. Pharmacol. Ther. 30, 245-252.
31. Coutinho, S. V., Plotsky, P. M., Sablad, M., Miller, J. C., Zhou, H., Bayati, A. I., McRoberts, J. A., and Mayer, E. A. (2002). Neonatal maternal separation alters stress induced responses to viscerosomatic nociceptive stimuli in rat. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G307-G316.
32. Cremon, C., Gargano, L., Morselli-Labate, A. M., Santini, D., Cogliandro, R. F., De Giorgio, R., Stanghellini, V., Corinaldesi, R., and Barbara, G. (2009). Mucosal immune activation in irritable bowel syndrome: gender dependence and association with digestive symptoms. Am. J. Gastroenterol. 104, 392-400.
33. Dainese, R., Galliani, E. A., De Lazzari, F., Di Leo, V., and Naccarato, R. (1999). Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am. J. Gastroenterol. 94, 1892-1897.
34. Dunlop, S. P., Coleman, N. S., Blackshaw, E., Perkins, A. C., Singh, G., Marsden, C. A., and Spiller, R. C. (2005). Abnormalities of 5 hydroxytryptamine metabolism in irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 3, 349-357.
35. Dunlop, S. P., Hebden, J., Campbell, E., Naesdal, J., Olbe, L., Perkins, A. C., and Spiller, R. C. (2006). Abnormal intestinal permeability in subgroups of diarrheapredominant irritable bowel syndromes. Am. J. Gastroenterol. 101, 1288-1294.
36. Dunlop, S. P., Jenkins, D., Neal, K. R., and Spiller, R. C. (2003a). Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 125, 1651-1659.
37. Dunlop, S. P., Jenkins, D., Neal, K. R., Naesdal, J., Borgaonker, M., Collins, S. M., and Spiller, R. C. (2003b). Randomized, doubleblind, placebo controlled trial of prednisolone in post infectious irritable bowel syndrome. Aliment. Pharmacol. Ther. 18, 77-84.
38. Dunlop, S. P., Jenkins, D., and Spiller, R. C. (2003c). Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am. J. Gastroenterol. 98, 1578-1583.
39. Egger, G., Liang, G., Aparicio, A., and Jones, P. A. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463.
40. Fass, R., Naliboff, B., Higa, L., Johnson, C., Kodner, A., Munakata, J., Ngo, J., and Mayer, E. A. (1998). Differential effect of long term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 115, 1363-1373.
41. Geeraerts, B., and Tack, J. (2008). Functional dyspepsia: past, present, and future. J. Gastroenterol. 43, 251-255.
42. Gershon, M. D. (2005). Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J. Clin. Gastroenterol. 39(5 Suppl 3), S184-S193.
43. Grider, J. R., and Jin, J. G. (1994). Distinct populations of sensory neurons mediate the peristaltic reflex elicited by muscle stretch and mucosal stimulation. J. Neurosci. 14(5 Pt 1), 2854-2860.
44. Gwee, K. A., Collins, S. M., Read, N. W., Rajnakova, A., Deng, Y., Graham, J. C., McKendrick, M. W., and Moochhala, S. M. (2003). Increased rectal mucosal expression of interleukin 1beta in recently acquired postinfectious irritable bowel syndrome. Gut 52, 523-526.
45. Gwee, K. A., Graham, J. C., McKendrick, M. W., Collins, S. M., Marshall, J. S., Walters, S. J., and Read, N. W. (1996). Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 347, 150-153.
46. Gwee, K. A., Leong, Y. L., Graham, C., McKendrick, M. W., Collins, S. M., Walters, S. J., Underwood, J. E., and Read, N. W. (1999). The role of psychological and biological factors in postinfective gut dysfunction. Gut 44, 400-406.
47. Howard, R., Rabins, P. V., Seeman, M. V., and Jeste, D. V. (2000). Late onset schizophrenia and very late onset schizophrenia like psychosis: an international consensus. The International Late Onset Schizophrenia Group. Am. J. Psychiatry 157, 172-178.
48. Keating, D. J., and Spencer, N. J. (2010). Release of 5 hydroxytryptamine from the mucosa is not required for the generation or propagation of colonic migrating motor complexes. Gastroenterology 138, 659-70 670 e1-2.
49. Kim, H. J., Camilleri, M., Carlson, P. J., Cremonini, F., Ferber, I., Stephens, D., McKinzie, S., Zinsmeister, A. R., and Urrutia, R. (2004). Association of distinct alpha(2) adreno ceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 53, 829-837.
50. King, R. A., Rotter, J. I., and Motulsky, A. G. (1992). The Genetic Bases of Common Diseases. Oxford: Oxford University Press.
51. Klooker, T. K., Braak, B., Koopman, K. E., Welting, O., Wouters, M. M., Van der Heide, S., Schemann, M., Bischoff, S. C., Van den Wijngaard, R. M., and Boeckxstaens, G. E. (2010). The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 59, 1213-1221.
52. Kristjansson, G., Venge, P., Wanders, A., Lööf, L., and Hällgren, R. (2004). Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 53, 1806-1812.
53. Kuiken, S. D., Lindeboom, R., Tytgat, G. N., and Boeckxstaens, G. E. (2005). Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 22, 157-164.
54. Kuiken, S. D., Tytgat, G. N., and Boeckxstaens, G. E. (2003). The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo controlled study. Clinical Gastroenterol. Hepatol. 1, 219-228.
55. Kumagai, T., Wakimoto, N., Yin, D., Gery, S., Kawamata, N., Takai, N., Komatsu, N., Chumakov, A., Imai, Y., and Koeffler, H. P. (2007). Histone deacetylase inhibitor, suberoy lanilide hydroxamic acid (Vorino stat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells. Int. J. Cancer 121, 656-665.
56. Lawless, M. W., Norris, S., O'Byrne, K. J., and Gray, S. G. (2009). Targeting histone deacetylases for the treatment of disease. J. Cell. Mol. Med. 13, 826-852.
57. Lee, D. Y., Park, H., Kim, W. H., Lee, S. I., Seo, Y. J., and Choi, Y. C. (2004). Serotonin transporter gene polymorphism in healthy adults and patients with irritable bowel syndrome. Korean J. Gastroenterol. 43, 18-22.
58. Lee, K. J., Kim,Y. B., Kim, J. H., Kwon, H. C., Kim, D. K., and Cho,S. W. (2008). The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J. Gastroenterol. Hepatol. 23, 1689-1694.
59. Lembo, T., Munakata, J., Mertz, H., Niazi, N., Kodner, A., Nikas, V., and Mayer, E. A. (1994). Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 107, 1686-1696.
60. Lembo, T., Munakata, J., Naliboff, B., Fullerton, S., and Mayer, E. A. (1997). Sigmoid afferent mechanisms in patients with irritable bowel syndrome. Dig. Dis. Sci. 42, 1112-1120.
61. Lettesjo, H., Hansson, T., Peterson, C., Ung, K. A., Ringström, G., Abrahamsson, H., and Simrén, M. (2006). Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Scand. J. Gastroenterol. 41, 54-59.
62. Li, Q. J., and Sarna, S. K. (2011). Developmental origins of irritable bowel syndrome (IBS) like symptoms: epigenetic dysregulation. Gastroenterology 140, S121.
63. Lowman, B. C., Drossman, D. A., Cramer, E. M., and McKee, D. C. (1987). Recollection of childhood events in adults with irritable bowel syndrome. J. Clin. Gastroenterol. 9, 324-330.
64. Lynn, P. A., and Blackshaw, L. A. (1999). In vitro recordings of afferent fibres with receptive fields in the serosa, muscle and mucosa of rat colon. J. Physiol. 518(Pt 1), 271-82.
65. Marshall, J. K., Thabane, M., Garg, A. X., Clark, W., Meddings, J., Collins, S. M., and WEL Investigators. (2004). Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment. Pharmacol. Ther. 20, 1317-1322.
66. McKendrick, M. W., and Read, N. W. (1994). Irritable bowel syndrome - post salmonella infection. J. Infect. 29, 1-3.
67. Mearin, F., Pérez-Oliveras, M., Perelló, A., Vinyet, J., Ibañez, A., Coderch, J., and Perona, M. (2005). Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one year follow up cohort study. Gastroenterology 129, 98-104.
68. Mertz, H., Fullerton, S., Naliboff, B., and Mayer, E. A. (1998). Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 42, 814-822.
69. Middel, P., Reich, K., Polzien, F., Blaschke, V., Hemmerlein, B., Herms, J., Korabiowska, M., and Radzun, H. J. (2001). Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease. Gut 49, 795-803.
70. Neal, K. R., Hebden, J., and Spiller, R. (1997). Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 314, 779-782.
71. Nuyt, A. M. (2008). Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models. Clin. Sci. 114, 1-17.
72. O'Sullivan, M., Clayton, N., Breslin, N. P., Harman, I., Bountra, C., McLaren, A., and O'Morain, C. A. (2000). Increased mast cells in the irritable bowel syndrome. Neurogastroenterol. Motil. 12, 449-457.
73. Park, C. H., Joo, Y. E., Choi, S. K., Rew, J. S., Kim, S. J., and Lee, M. C. (2003). Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea predominant irritable bowel syndrome. J. Korean Med. Sci. 18, 204-210.
74. Park, J. H., Rhee, P. L., Kim, G., Lee, J. H., Kim, Y. H., Kim, J. J., Rhee, J. C., and Song, S. Y. (2006). Enteroen docrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea predominant irritable bowel syndrome. Neurogastroenterol. Motil. 18, 539-546.
75. Park, M. I., and Camilleri, M. (2005). Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol. Clin. North Am. 34, 305-317.
76. Pata,C., Erdal, M. E., Derici, E.,Yazar, A., Kanik, A., and Ulu, O. (2002). Serotonin transporter gene polymorphism in irritable bowel syndrome. Am. J. Gastroenterol. 97, 1780-1784.
77. Pont, S. J., Grijalva, C. G., Griffin, M. R., Scott, T. A., and Cooper, W. O. (2009). National rates of diarrhea associated ambulatory visits in children. J. Pediatr. 155, 56-61.
78. Posserud, I., Syrous, A., Lindström, L., Tack, J., Abrahamsson, H., and Simrén, M. (2007). Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 133, 1113-1123.
79. Pravda, J. (2005). Radical induction theory of ulcerative colitis. Wor ld J. Gastroenterol. 11, 2371-2384.
80. Prior, A., Maxton, D. G., and Whorwell, P. J. (1990). Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut 31, 458-462.
81. Protic, M., Jojic, N., Bojic, D., Milutinovic, S., Necic, D., Bojic, B., Svorcan, P., Krstic, M., and Popovic, O. (2005). Mechanism of diarrhea in microscopic colitis. World J. Gastroenterol. 11, 5535-5539.
82. Rao, S. S., Sadeghi, P., Beaty, J., and Kavlock, R. (2004). Ambulatory 24hour colonic manometry in slowtransit constipation. Am. J. Gastroenterol. 99, 2405-2416.
83. Read, N. W. (1986). Diarrhee motrice. Clin. Gastroenterol. 15, 657-686.
84. Saada, N., Dai, B., Echetebu, C., Sarna, S. K., and Palade, P. (2003). Smooth muscle uses another promoter to express primarily a form of human Ca(V)1.2 Lc type calcium channel different from the principal heart form. Biochem. Biophys. Res. Commun. 302, 23-28.
85. Saito, Y. A., and Talley, N. J. (2008). Genetics of irritable bowel syndrome. Am. J. Gastroenterol. 103, 2100-2104; quiz 2105.
86. Saps, M., Pensabene, L., Di Martino, L., Staiano, A., Wechsler, J., Zheng, X., and Di Lorenzo, C. (2008). Post infectious functional gastrointestinal disorders in children. J. Pediatr. 152, 812-816, 816.e1.
87. Sarna, S. K. (2006). Molecular, functional and pharmacological targets for the development of gut promotility drugs. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G545-G555.
88. Sarna, S. K. (2007). Enteric descending and afferent neural signaling stimulated by giant migrating contractions: essential contributing factors to visceral pain. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G572-G581.
89. Sarna, S. K. (2010). Colonic Motility: From Bench Side to Bedside, in Colonic Motility. San Rafael, CA: Morgan and Claypool Life Sciences, 1-140.
90. Shi, X. Z., Choudhury, B. K., Pasricha, P. J., and Sarna, S. K. (2007). A novel role of VIP in colonic motility function: induction of excitation transcription coupling in smooth muscle cells. Gastroenterology 132, 1388-1400.
91. Shi, X. Z., Winston, J. H., and Sarna, S. K. (2011). Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G41-G51.
92. Silberer, H., Küppers, B., Mickisch, O., Baniewicz, W., Drescher, M., Traber, L., Kempf, A., and Schmidt Gayk, H. (2005). Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin. Lab. 51, 117-126.
93. Spencer, N. J., Nicholas, S. J., Robinson, L., Kyloh, M., Flack, N., Brookes, S. J., Zagorodnyuk, V. P., and Keating, D. J. (2011). Mechanisms underlying distension evoked peristalsis in guinea pig distal colon: is there a role for enterochromaffin (EC) cells? Am. J. Physiol. Gastrointest. Liver Physiol. PMID: 21700904. [Epub ahead of print].
94. Spiller, R. C. (2003). Postinfectious irritable bowel syndrome. Gastroenterology 124, 1662-1671.
95. Spiller, R. C. (2007). Role of infection in irritable bowel syndrome. J. Gastroenterol. 42(Suppl. 17), 41-47.
96. Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., and Neal, K. R. (2000). Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post dysenteric irritable bowel syndrome. Gut 47, 804-811.
97. Sydora, B. C., Tavernini, M. M., Doyle, J., and Fedorak, R. N. (2006a). A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor alpha gene deficient mice. Inflamm. Bowel Dis. 12, 750-757.
98. Sydora, B. C., Martin, S. M., Lupicki, M., Dieleman, L. A., Doyle, J., Walker, J. W., and Fedorak, R. N. (2006b). Bacterial antigens alone can influence intestinal barrier integrity, but live bacteria are required for initiation of intestinal inflammation and injury. Inflamm. Bowel Dis. 12, 429-436.
99. Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., and Bjarnason, I. (2002). Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123, 450-460.
100. Tornblom, H., Lindberg, G., Nyberg, B., and Veress, B. (2002). Full thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 123, 1972-1979.
101. Van der Veek, P. P., Van den Berg, M., De Kroon, Y. E., Verspaget, H. W., and Masclee, A. A. (2005). Role of tumor necrosis factor alpha and interleukin 10 gene polymorphisms in irritable bowel syndrome. Am. J. Gastroenterol. 100, 2510-2516.
102. Van Kerkhoven, L. A., Laheij, R. J., and Jansen, J. B. (2007). Meta analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment. Pharmacol. Ther. 26, 979-986.
103. Venge, P., and Peterson, C. (1989). "Eosinophil biochemistry and killing mechanisms," in Eosinophils in Asthma, eds J. Morley and I. Colditz (New York: Academic Press).
104. Vermeire, S., Van Assche, G., and Rutgeerts, P. (2010). Postinfectious irritable bowel syndrome: a genetic link identified? Gastroenterology 138, 1246-1249.
105. Villani, A. C., Lemire, M., Thabane, M., Belisle, A., Geneau, G., Garg, A. X., Clark, W. F., Moayyedi, P., Collins, S. M., Franchimont, D., and Marshall, J. K. (2010). Genetic risk factors for post infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 138, 1502-1513.
106. Wang, L. H., Fang, X. C., and Pan, G. Z. (2004). Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 53, 1096-1101.
107. Wildt, S., Madsen, J. L., and Rumessen, J. J. (2006). Small bowel permeability in collagenous colitis. Scand. J. Gastroenterol. 41, 1044-1049.
108. Winston, J. H., and Sarna, S. K. (2011). Neonatal inflammatory insult to the colon results in functional dyspepsia like gastric hypersensitivity in adulthood by epigenetic dysregulation. Gastroenterology 140, S23-S24.
109. Yeo, A., Boyd, P., Lumsden, S., Saunders, T., Handley, A., Stubbins, M., Knaggs, A., Asquith, S., Taylor, I., Bahari, B., Crocker, N., Rallan, R., Varsani, S., Montgomery, D., Alpers, D. H., Dukes, G. E., Purvis, I., and Hicks, G. A. (2004). Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 53, 1452-1458.
110. Zhou, Q., Zhang, B., and Verne, G. N. (2009). Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain 146, 41-46.